Melcor Real Estate Investment Trust (TSE:MR) – Investment analysts at Desjardins boosted their FY2017 EPS estimates for shares of Melcor Real Estate Investment Trust in a research report issued to clients and investors on Thursday. Desjardins analyst M. Markidis now anticipates that the company will post earnings of $1.03 per share for the year, up from their prior forecast of $1.02. Desjardins also issued estimates for Melcor Real Estate Investment Trust’s FY2019 earnings at $1.02 EPS.

COPYRIGHT VIOLATION NOTICE: This story was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this story on another publication, it was stolen and republished in violation of United States & international trademark & copyright laws. The correct version of this story can be accessed at https://www.americanbankingnews.com/2017/08/07/fy2017-eps-estimates-for-melcor-real-estate-investment-trust-increased-by-desjardins-tsemr.html.

The firm also recently declared a monthly dividend, which will be paid on Tuesday, August 15th. Stockholders of record on Monday, July 31st will be paid a $0.056 dividend. The ex-dividend date is Thursday, July 27th. This represents a $0.67 annualized dividend and a dividend yield of Infinity.

About Melcor Real Estate Investment Trust

Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature.

Receive News & Ratings for Melcor Real Estate Investment Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Melcor Real Estate Investment Trust and related companies with MarketBeat.com's FREE daily email newsletter.